Well Lead Medical Co., Ltd.

XSSC:603309 Stock Report

Market Cap: CN¥3.8b

Well Lead Medical Future Growth

Future criteria checks 4/6

Well Lead Medical is forecast to grow earnings and revenue by 20.9% and 20.1% per annum respectively. EPS is expected to grow by 20.7% per annum. Return on equity is forecast to be 15.5% in 3 years.

Key information

20.9%

Earnings growth rate

20.7%

EPS growth rate

Medical Equipment earnings growth26.5%
Revenue growth rate20.1%
Future return on equity15.5%
Analyst coverage

Low

Last updated22 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:603309 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,338348N/A4871
12/31/20251,971290N/A4281
12/31/20241,637240N/A3571
9/30/20241,471215-90232N/A
6/30/20241,412206-115241N/A
3/31/20241,335191-172193N/A
12/31/20231,388192-135223N/A
9/30/20231,336173-80239N/A
6/30/20231,38517668298N/A
3/31/20231,424180225431N/A
12/31/20221,363167210391N/A
9/30/20221,358162212354N/A
6/30/20221,276142144280N/A
3/31/20221,20012287213N/A
12/31/20211,11910678187N/A
9/30/20211,0549556173N/A
6/30/20211,05510397200N/A
3/31/20211,194168108214N/A
12/31/20201,131153136228N/A
9/30/20201,125156120224N/A
6/30/20201,089147106218N/A
3/31/202095710976185N/A
12/31/201999412166179N/A
9/30/201995712775171N/A
6/30/201988311232118N/A
3/31/20198097931114N/A
12/31/2018746651190N/A
9/30/201868254-972N/A
6/30/201865850N/A82N/A
3/31/201864456N/A64N/A
12/31/201763065N/A74N/A
9/30/201759871N/A78N/A
6/30/201757684N/A79N/A
3/31/201753180N/A71N/A
12/31/201651579N/A85N/A
9/30/201652382N/A80N/A
6/30/201653384N/A91N/A
3/31/201655392N/A78N/A
12/31/201554991N/A81N/A
9/30/201553284N/A81N/A
6/30/201550677N/A75N/A
3/31/201550469N/A111N/A
12/31/201449668N/A107N/A
12/31/201343764N/A73N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603309's forecast earnings growth (20.9% per year) is above the savings rate (2.8%).

Earnings vs Market: 603309's earnings (20.9% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 603309's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 603309's revenue (20.1% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 603309's revenue (20.1% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 603309's Return on Equity is forecast to be low in 3 years time (15.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y